Effect of dopamine on adenosine 3′,5′-cyclic monophosphate levels in human platelets
- 1 March 1993
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 24 (2) , 435-438
- https://doi.org/10.1016/0306-3623(93)90329-v
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Hormonal Regulation of Cyclic Nucleotide Phosphodiesterases*Endocrine Reviews, 1991
- Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human plateletsGeneral Pharmacology: The Vascular System, 1991
- Recent Experimental and Conceptual Advances in Drug Receptor Research in the Cardiovascular SystemPublished by Elsevier ,1988
- Identification of D1-like dopamine receptors on human blood plateletsLife Sciences, 1988
- Dopamine receptors: molecular structure and functionMolecular and Cellular Endocrinology, 1987
- 3H-spiroperidol binding sites in blood plateletsBiochemical and Biophysical Research Communications, 1987
- Platelet β‐adrenoceptorsBritish Journal of Pharmacology, 1983
- The dopamine receptor in the intermediate lobe of the rat pituitary gland is negatively coupled to adenylate cyclaseLife Sciences, 1982
- Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.Circulation, 1981
- Characterization of ?- and ?-adrenergic receptors linked to human platelet adenylate cyclaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1978